Monrovia, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- eXoZymes, Inc. (Nasdaq: EXOZ) (“eXoZymes”) – a pioneer of AI-engineered enzymes that can ...

Cathie Wood's ARK ETFs have made a series of significant trades on Friday, February 14, 2025, continuing their dynamic investment strategy in the tech and biotech sectors. The most notable move was ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

XoZymes replaces traditional chemical production methods with an approach that integrates widely available feedstocks like sugar and biomass with advanced enzymes engineered to thrive outside living ...

Rebranding Invizyne Technologies, Inc to eXoZymes Inc.Changing NASDAQ ticker from IZTC to EXOZIntroducing but not trademarking “exozymes” as a ...

Sam Finn, a senior research associate at Zymo Research working with the Oncology Diagnostic Team, helped to host this interactive game booth at the “BioFestival” on Tuesday.

Synthetic cells that look just like natural cells but are chemically reversed could outcompete other living organisms − with ...

Synthetic biologists from Yale were able to re-write the genetic code of an organism—a novel genomically recoded organism ...

Discovering Twist Bioscience: A Closer Look Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology.

Stay informed and make data-driven decisions with our Ratings Table. Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the ...

(Goold et al., Nature Communications, 2025) "This is a landmark moment in synthetic biology," says molecular microbiologist Sakkie Pretorius, from Macquarie University. "It is the final piece of a ...

Our biological sciences students explore the complexities of life and work to address global challenges in biology. Our faculty advance knowledge in a wide range of disciplines within the biological ...